Compressed injection pill for oral insulin delivery
8 February 2019 | By European Pharmaceutical Review
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
List view / Grid view
Analytical techniques
FDA approval for Cablivi to treat rare clotting disorder
7 February 2019 | By European Pharmaceutical Review
The FDA has approved the first specific therapy for the rare blood clotting disorder, acquired thrombotic thrombocytopenic purpura (aTTP)...
Researchers launch virtual docking library to aid drug discovery
6 February 2019 | By European Pharmaceutical Review
Researchers have launched a large virtual docking library expected to grow to more than one billion molecules by 2020 which could aid drug discovery...
No association found between trazodone and reduced risk of dementia
6 February 2019 | By Iqra Farooq (European Pharmaceutical Review)
The antidepressant drug, trazodone, taken for anxiety and depression, has been found not to be linked to a reduced risk of dementia...
PharmaFluidics’ new product launch steers ‘on-a-chip’ separations of complex biological samples to new heights
6 February 2019 | By PharmaFluidics
PharmaFluidics NV is a game-changing innovator in the field of analytical chromatography. The company has devised a fundamentally new way of performing separations by creating nano-LC columns on a silicon chip...
Vaccines and infectious diseases in the ageing population project begins
5 February 2019 | By European Pharmaceutical Review
The VITAL project addresses the challenges to medicines for the ageing population, with millions in grants and sponsors going into research...
Psoriasis treatment linked to improvement in heart disease
5 February 2019 | By European Pharmaceutical Review
Treatments for psoriasis could help prevent heart disease in patients with the skin condition, with patients having an 8 percent reduction in their risk...
Application Note: Highly selective bioanalytical quantitation method for analysis of R and S amlodipine enantiomers in human plasma using LC-MS/MS
5 February 2019 | By Sciex
Amlodipine is an angioselective calcium channel blocker used to treat high blood pressure, chest pain and other conditions caused by coronary artery disease.
Efforts to advance the development of complex generic drugs
4 February 2019 | By European Pharmaceutical Review
The FDA has issued a statement to promote the development of complex generic drugs to ensure access for patients and healthy drug competition...
Late-stage pipeline drugs could compete with only treatment for SMA
4 February 2019 | By European Pharmaceutical Review
A number of drugs currently in their late stages in the development process could see competition for nusinersen, the only current SMA treatment, rise...
Computational method could reduce the risk of drug formulations
1 February 2019 | By European Pharmaceutical Review
A team of researchers have developed a computational method using an algorithm to develop formulations for drugs so they function properly...
Public consultation on key principles for ePI of EU medicines
1 February 2019 | By European Pharmaceutical Review
The European Medicine Agency has launched a six month consultation on the principles that will form the basis of the electronic product information (ePI)...
Extended recall of ibuprofen oral suspension drops
31 January 2019 | By European Pharmaceutical Review
The recall of specific batches of children's ibuprofen has been extended by the manufacture of the product as it has a greater concentration of ibuprofen...
Combined MRI and SPECT imaging could guide ventricular tachycardia
31 January 2019 | By Iqra Farooq (European Pharmaceutical Review)
A study has found that a combination of imaging techniques could guide and improve current ablation strategies used to treat patients...
Proposed Medicare reforms spark comments about drugs
30 January 2019 | By European Pharmaceutical Review
Reforms that have been proposed by the Centers for Medicare and Medicaid Services have sparked comments from officials and companies alike...
Follow: